Advanced Technology for Rare Cell Analysis

Immunicon offers products and services for cell analysis and molecular research. Our CellTracks® instruments and reagents are used to capture, count and characterize rare cells including circulating tumor cells (CTCs) in cancer patients and circulating endothelial cells (CECs), which are elevated in a variety of diseases.

We have expanded our molecular offering with the introduction of Poseidon™ Repeat-Free™  FISH Probes.  RF Poseidon FISH probes were developed using Repeat-Free™  technology. 

The top names in Big Pharma are working with Immunicon Pharma Services. We offer clinical trial testing services to incorporate rare cell molecular analysis and FISH testing into clinical research.

Our life science research product portfolio includes the EasyCount® System for counting nucleated cells.

   

The testing services described in this web site will be conducted in-house by Immunicon for pharmaceutical research. Any product that is developed through this research and is intended for commercial distribution must obtain applicable FDA regulatory approval or clearance before commercial distribution or marketing. Immunicon cellular analysis products are distributed exclusively in the field of cancer through Veridex, LLC, a Johnson and Johnson company under the CellSearch™ brand name. The CellSearch™ Circulating Tumor Cell Kit is cleared for in vitro diagnostics use as an aid to monitoring patients with metastatic breast cancer, metastatic prostate cancer and metastatic colorectal cancer. Please visit the Veridex website, www.veridex.com, for further information regarding IVD use and purchase of products.